Europe - EPA:ALCAR - FR0010907956 - Common Stock
The current stock price of ALCAR.PA is 0.1106 EUR. In the past month the price decreased by -52.73%. In the past year, price decreased by -94.91%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 27.12 | 195.87B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 54.06 | 131.97B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 34.73 | 122.99B | ||
2M6.DE | MEDTRONIC PLC | 17.14 | 102.88B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 19.81 | 53.19B | ||
BOX.DE | BECTON DICKINSON AND CO | 13.25 | 45.83B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 28.78 | 36.67B | ||
1RMD.MI | RESMED INC | 28.58 | 33.81B | ||
DC4.DE | DEXCOM INC | 43.45 | 24.54B | ||
1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.68 | 23.13B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 16.59 | 23.00B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 16.57 | 22.98B |
Carmat SA is a medtech that designs, manufactures and markets the Aeson artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 153 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. The company specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
CARMAT
36, avenue de l'Europe
Velizy-Villacoublay ILE-DE-FRANCE FR
Employees: 162
Phone: 33139456450
The current stock price of ALCAR.PA is 0.1106 EUR. The price decreased by -1.25% in the last trading session.
The exchange symbol of CARMAT is ALCAR and it is listed on the Euronext Paris - Matif exchange.
ALCAR.PA stock is listed on the Euronext Paris - Matif exchange.
10 analysts have analysed ALCAR.PA and the average price target is 5.1 EUR. This implies a price increase of 4511.21% is expected in the next year compared to the current price of 0.1106. Check the CARMAT stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CARMAT (ALCAR.PA) has a market capitalization of 7.09M EUR. This makes ALCAR.PA a Nano Cap stock.
CARMAT (ALCAR.PA) currently has 162 employees.
CARMAT (ALCAR.PA) has a resistance level at 0.18. Check the full technical report for a detailed analysis of ALCAR.PA support and resistance levels.
The Revenue of CARMAT (ALCAR.PA) is expected to grow by 103.62% in the next year. Check the estimates tab for more information on the ALCAR.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALCAR.PA does not pay a dividend.
CARMAT (ALCAR.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.21).
ChartMill assigns a fundamental rating of 2 / 10 to ALCAR.PA. Both the profitability and financial health of ALCAR.PA have multiple concerns.
Over the last trailing twelve months ALCAR.PA reported a non-GAAP Earnings per Share(EPS) of -1.21. The EPS increased by 44.5% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -121.13% | ||
ROE | N/A | ||
Debt/Equity | N/A |
10 analysts have analysed ALCAR.PA and the average price target is 5.1 EUR. This implies a price increase of 4511.21% is expected in the next year compared to the current price of 0.1106.
For the next year, analysts expect an EPS growth of 53.31% and a revenue growth 103.62% for ALCAR.PA